Back to results
US 6,284,734 B1Granted
Inhibitors against prostate-specific antigen
AssigneeJCR Pharmaceuticals Co., Ltd.
InventorsKozue Shibata, Jun-ichi Kajihara, Kazuyuki Hirano
Life of this patent
Estimating the term…
Abstract
According to the present invention, there are provided inhibitors against prostate-specific antigen which comprise as a minimum unit a peptide consisting of Gly-Phe-Tyr-Lys-Lys-Lys-Gln-Ser-Arg, and such inhibitors can be expected to constitute a therapeutic drug against prostate carcinoma and prostate hyperplasia.
Claims2
An isolated peptide exhibiting inhibitory activity against prostate specific antigen, which peptide comprises the formula (SEQ ID NO:
- 1):
- Gly-Phe-Tyr-Lys-Lys-Lys-Gln-Ser-Arg.
Dependencies are inferred from the claim text.